{"id":"W1986396848","doi":"10.1016/j.drup.2008.04.001","title":"Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation de France; American Association for Cancer Research","keywords":"Medicine; Biomarker; Biomarker discovery; Trastuzumab; Imatinib; Drug; Clinical trial; Breast cancer; Druggability; Personalized medicine; Sunitinib; Oncology; Cancer; Pharmacology; Bioinformatics; Cancer research; Internal medicine; Biology; Proteomics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001417958,0.0002812232,0.001034031,0.0002438361,0.00009964693,0.00004018622,0.00027048,0.0001505932,0.000006599477],"category_scores_gemma":[0.0003789114,0.0001934426,0.0001262515,0.0003547504,0.000496749,0.00007105821,0.00006441647,0.0002534679,0.000001858674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001130142,"about_ca_system_score_gemma":0.0002182159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000010476,"about_ca_topic_score_gemma":0.0000557923,"domain_scores_codex":[0.9975621,0.0002400079,0.000811452,0.0005712656,0.0004602918,0.0003549294],"domain_scores_gemma":[0.9983803,0.000529208,0.0004248497,0.0004517404,0.0001415042,0.00007239567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000111361,0.0001123102,0.0004552274,0.1043303,0.0002133804,0.00003086095,0.001114276,2.869265e-8,0.000006997485,0.0002651465,0.009955782,0.8834043],"study_design_scores_gemma":[0.0004174492,0.00002738478,0.0006188655,0.01291823,0.0001808089,0.00001800541,0.000434662,0.00001101993,0.00004260354,0.00006999879,0.9850876,0.0001733453],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004401326,0.9947869,0.000001897446,0.001966704,0.00009253107,0.00241609,0.00009307302,0.00001536133,0.0001873581],"genre_scores_gemma":[0.001060572,0.997253,0.0004257958,0.00002089951,0.0001022122,0.0007384467,0.0001286308,0.00005194875,0.0002185001],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9751319,"threshold_uncertainty_score":0.7888359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1392766723441191,"score_gpt":0.4201719401740726,"score_spread":0.2808952678299535,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}